基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
We propose a new nonparametric method for assessing non-inferiority of an experimental therapy compared to a standard of care. The ratio μE/μR of true median survival times is the parameter of interest. This is of considerable interest in clinical trials of generic drugs. We think of the ratio mE/mR of the sample medians as a point estimate of the ratioμE/μR. We use the Fieller-Hinkley distribution of the ratio of two normally distributed random variables to derive an unbiased level-α test of inferiority null hypothesis, which is stated in terms of the ratio μE/μR and a pre-specified fixed non-inferiority margin δ. We also explain how to assess equivalence and non-inferiority using bootstrap equivalent confidence intervals on the ratioμE/μR. The proposed new test does not require the censoring distributions for the two arms to be equal and it does not require the hazard rates to be proportional. If the proportional hazards assumption holds good, the proposed new test is more attractive. We also discuss sample size determination. We claim that our test procedure is simple and attains adequate power for moderate sample sizes. We extend the proposed test procedure to stratified analysis. We propose a “two one-sided tests” approach for assessing equivalence.
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 New Tests for Assessing Non-Inferiority and Equivalence from Survival Data
来源期刊 统计学期刊(英文) 学科 医学
关键词 Right-Censored Data Kaplan-Meier ESTIMATE BOOTSTRAP Standard Error GENERIC DRUGS
年,卷(期) 2013,(2) 所属期刊栏目
研究方向 页码范围 55-64
页数 10页 分类号 R73
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2013(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
Right-Censored
Data
Kaplan-Meier
ESTIMATE
BOOTSTRAP
Standard
Error
GENERIC
DRUGS
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
统计学期刊(英文)
半月刊
2161-718X
武汉市江夏区汤逊湖北路38号光谷总部空间
出版文献量(篇)
584
总下载数(次)
0
总被引数(次)
0
论文1v1指导